Patents Assigned to XI'AN LIBANG PHARMACEUTICAL TECHNOLOGY CO., LTD.
  • Patent number: 8956659
    Abstract: Fulvestrant nanosphere/microsphere and preparation method and use thereof are provided in the present invention. The carrier material of the fulvestrant nanosphere/microsphere is methoxy ended polyethylene glycol-polylactic acid block copolymer. The nanosphere/microsphere is prepared by solvent-nonsolvent method, in-liquid drying method and/or spray drying method, and has the features of high drug loading and high encapsulation efficiency, controllable release of medicine and no irritant to application site or blood vessel. The fulvestrant nanosphere/microsphere can be used to treat metastatic advanced breast cancer in post-menopausal woman.
    Type: Grant
    Filed: October 17, 2013
    Date of Patent: February 17, 2015
    Assignee: Xi'an Libang Pharmaceutical Technology Co., Ltd.
    Inventors: Renle Hu, Jiucheng Wang, Yaqi Jiao, Hua Liang, Duohao Ding
  • Publication number: 20140042654
    Abstract: Fulvestrant nanosphere/microsphere and preparation method and use thereof are provided in the present invention. The carrier material of the fulvestrant nanosphere/microsphere is methoxy ended polyethylene glycol-polylactic acid block copolymer. The nanosphere/microsphere is prepared by solvent-nonsolvent method, in-liquid drying method and/or spray drying method, and has the features of high drug loading and high encapsulation efficiency, controllable release of medicine and no irritant to application site or blood vessel. The fulvestrant nanosphere/microsphere can be used to treat metastatic advanced breast cancer in post-menopausal woman.
    Type: Application
    Filed: October 17, 2013
    Publication date: February 13, 2014
    Applicant: Xi'an Libang Pharmaceutical Technology Co., Ltd.
    Inventors: Renle Hu, Jiucheng Wang, Yaqi Jiao, Hua Liang, Duohao Ding
  • Patent number: 8586092
    Abstract: Fulvestrant nanosphere/microsphere and preparation method and use thereof are provided in the present invention. The carrier material of the fulvestrant nanosphere/microsphere is methoxy ended polyethylene glycol-polylactic acid block copolymer. The nanosphere/microsphere is prepared by solvent-nonsolvent method, in-liquid drying method and/or spray drying method, and has the features of high drug loading and high encapsulation efficiency, controllable release of medicine and no irritant to application site or blood vessel. The fulvestrant nanosphere/microsphere can be used to treat metastatic advanced breast cancer in post-menopausal woman.
    Type: Grant
    Filed: August 31, 2009
    Date of Patent: November 19, 2013
    Assignee: Xi'an Libang Pharmaceutical Technology Co., Ltd.
    Inventors: Renle Hu, Jiucheng Wang, Yaqi Jiao, Hua Liang, Duohao Ding
  • Publication number: 20110318420
    Abstract: Fulvestrant nanosphere/microsphere and preparation method and use thereof are provided in the present invention. The carrier material of the fulvestrant nanosphere/microsphere is methoxy ended polyethylene glycol-polylactic acid block copolymer. The nanosphere/microsphere is prepared by solvent-nonsolvent method, in-liquid drying method and/or spray drying method, and has the features of high drug loading and high encapsulation efficiency, controllable release of medicine and no irritant to application site or blood vessel. The fulvestrant nanosphere/microsphere can be used to treat metastatic advanced breast cancer in post-menopausal woman.
    Type: Application
    Filed: August 31, 2009
    Publication date: December 29, 2011
    Applicant: XI'AN LIBANG PHARMACEUTICAL TECHNOLOGY CO., LTD.
    Inventors: Renle Hu, Jiucheng Wang, Yaqi Jiao, Hua Liang, Duohao Ding